Vir BiotechnologyVIR
那斯達克 · USD
9.65
+0.44
(+4.78%)
盤中 08/21 10:35 (UTC+8)
08/21 10:35 (UTC+8)
Vir BiotechnologyVIR
9.65
+0.44
(+4.78%)
財務數據
損益表
- 0.56
- 0.03
- 0.02
- 0.12
- 0.03
- 0.01
- 0.00
- 0.64
- 0.00
- 2.39
- 235.83
- -94.55
- -22.60
- 419.92
- -75.50
- -59.96
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 238,946 | -41 | 64,070 | -65 | 1,214 | 3,032 | 12,374 | 2,380 | 3,075 | 56,376 |
營業成本 | - | - | 26 | -11 | 11 | - | 684 | 50 | 52 | 59 |
營業毛利 | 238,946 | -41 | 64,044 | -54 | 1,203 | 3,032 | 11,690 | 2,330 | 3,023 | 56,317 |
營業費用 | 165,479 | 132,249 | 111,965 | 173,389 | 119,620 | 142,579 | 128,840 | 233,634 | - | - |
研發費用 | 135,283 | 108,922 | 88,349 | 151,463 | 97,509 | 118,645 | 106,083 | 195,178 | 105,113 | 100,125 |
推銷及管理費用 | 30,196 | 23,339 | 23,616 | 22,231 | 22,283 | 23,944 | 26,701 | 25,744 | 30,265 | 36,273 |
非經常性項目費用 | - | - | - | - | -172 | -10 | -3,944 | 12,712 | 26,275 | - |
其他營業費用 | - | -12 | - | -305 | - | - | - | - | - | - |
營業利益 | 73,467 | -132,290 | -47,921 | -173,443 | -118,417 | -139,547 | -117,150 | -231,304 | -158,630 | -80,081 |
其他收入及費用 | 8,515 | - | 7,467 | - | 11,011 | 12,216 | 13,647 | 16,634 | 18,311 | 20,996 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 80,259 | -125,525 | -43,060 | -162,973 | -110,788 | -120,949 | -104,675 | -213,540 | -139,890 | -65,000 |
所得稅 | 179 | 170 | -137 | 168 | 170 | 16 | -86 | 177 | -1,512 | 276 |
稅後純益 | 80,080 | -125,695 | -42,923 | -163,141 | -110,958 | -120,965 | -104,589 | -213,717 | -138,378 | -65,276 |
基本每股稅後盈餘(元) | 0.48 | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 | -0.76 | -1.56 | -1.02 | -0.48 |
稀釋每股稅後盈餘(元) | 0.56 | -0.85 | -0.30 | -1.18 | -0.80 | -0.88 | -0.76 | -1.57 | -1.02 | -0.48 |
基本平均股數(千股) | 167719.00 | 147356.00 | 139232.00 | 138930.00 | 138447.00 | 137468.00 | 136808.00 | 136653.00 | 136233.00 | 135280.00 |
稀釋平均股數(千股) | 168879.00 | 147356.00 | 139232.00 | 138930.00 | 138447.00 | 137468.00 | 136808.00 | 136653.00 | 136233.00 | 135280.00 |
還原基本每股稅後盈餘(元) | 0.48 | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 | -0.76 | -1.56 | -1.02 | -0.48 |
還原稀釋每股稅後盈餘(元) | 0.56 | -0.85 | -0.30 | -1.18 | -0.80 | -0.88 | -0.76 | -1.57 | -1.02 | -0.48 |
還原基本平均股數(千股) | 167,719 | 147,356 | 139,232 | 138,930 | 138,447 | 137,468 | 136,808 | 136,653 | 136,233 | 135,280 |
還原稀釋平均股數(千股) | 168,879 | 147,356 | 139,232 | 138,930 | 138,447 | 137,468 | 136,808 | 136,653 | 136,233 | 135,280 |
EBITDA(千元) | 83,383 | -122,714 | -38,613 | -159,975 | -105,350 | -113,993 | -99,621 | -210,290 | -132,993 | -60,245 |